Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-165504
Filing Date
2025-07-25
Accepted
2025-07-25 16:50:12
Documents
5
Period of Report
2025-07-25

Document Format Files

Seq Description Document Type Size
1 6-K d92305d6k.htm 6-K 33261
2 EX-1.1 d92305dex11.htm EX-1.1 197746
3 EX-5.1 d92305dex51.htm EX-5.1 63544
4 GRAPHIC g92305dsp51.jpg GRAPHIC 31124
5 GRAPHIC g92305dsp52a.jpg GRAPHIC 4248
  Complete submission text file 0001193125-25-165504.txt   344768
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 251152199
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)